Cocrystal Pharma, Inc.
NASDAQCOCP short interest fell 27% over the past week to 11.6% of float, down from a peak of 27.3% on April 7 as shares rose 43% over the month.
Short interest % of float, cost to borrow, utilization, and put/call ratio for COCP are part of the ORTEX premium tier. Sign up to read the live numbers alongside the analysis.
Snapshot as of 7 May 2026
No long-form analysis yet for COCP. Pulse alerts and the live data picture are available on ORTEX.
Open COCP on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for COCP — free to start on ORTEX.
Sign up for free →Open COCP on ORTEX